Daybreak is a custom-fitted mandibular advancement device for mild to moderate obstructive sleep apnea. It replaces CPAP with a mask-free, fully at-home system that covers sleep testing, physician diagnosis, and a custom device built from dental impressions taken at home.
A peer-reviewed Cedars-Sinai study of 185 patients confirmed a 63.3% AHI reduction in mild OSA patients, with 83% meeting SHER treatment success criteria. The device is FDA-cleared, accepted by most insurance plans, and endorsed by both the AASM and AADSM as a first-line CPAP alternative.
Trustpilot shows a 3.0 out of 5 score: strong clinical outcomes from satisfied users alongside recurring complaints about delays and support responsiveness. This review covers how Daybreak works, what the research shows, and what to know before ordering.
What Is Daybreak Sleep Apnea?
Daybreak is a custom-fitted mandibular advancement device designed to treat mild to moderate obstructive sleep apnea without CPAP machines, masks, or clinic visits. Unlike over-the-counter mouthpieces, Daybreak is dispensed through a clinical pathway that covers at-home testing, custom fabrication, and physician oversight from start to finish.
Obstructive sleep apnea is a condition where the airway collapses repeatedly during sleep. Each collapse triggers oxygen drops, repeated arousals, and long-term health risks. An estimated 54 million Americans have OSA, most of them undiagnosed or undertreated.
Here’s the thing: most CPAP users quit within the first year. Why does that matter? Because untreated sleep apnea raises the risk of cardiovascular disease, cognitive impairment, and metabolic disorders. Daybreak targets that dropout gap with a mask-free alternative backed by peer-reviewed research.
Who Is Daybreak Designed For?
Daybreak is designed for adults with mild to moderate obstructive sleep apnea, especially those who have already tried CPAP and found it too uncomfortable to use consistently. The American Academy of Sleep Medicine (AASM) and the American Academy of Dental Sleep Medicine (AADSM) both endorse mandibular advancement devices as a first-line treatment for mild OSA.
The device is also FDA-cleared for snoring. Patients without a confirmed OSA diagnosis but with chronic snoring can start with Daybreak’s at-home sleep test before committing to the device pathway.
Daybreak is not for severe OSA patients. In those cases, CPAP remains the only guideline-endorsed standard of care. No oral device substitutes for the continuous pressure required when AHI exceeds 30 events per hour.
Daybreak Is Best For:
- Adults with mild to moderate obstructive sleep apnea
- CPAP-intolerant patients seeking a mask-free alternative
- Undiagnosed patients who want at-home sleep testing
- Patients who prefer a fully remote care pathway
How Does Daybreak Work?
Daybreak works by repositioning the lower jaw forward during sleep to physically widen the upper airway and prevent the soft tissue collapse that causes most obstructive sleep apnea events. This technique, mandibular advancement therapy, has been a clinically established OSA treatment for more than 30 years according to the AASM.
The process follows four steps: at-home sleep test, physician prescription, at-home dental impressions, and custom device fabrication with delivery. Daybreak’s team then guides weekly titration remotely after the device arrives.
The titration protocol starts at 1 mm of jaw advancement and increases by 1 mm increments each week. And here is the key finding: a retrospective cohort study at Cedars-Sinai found that significant AHI reductions occurred with minimal total advancement. Small adjustments produced large results.
How Daybreak Works (Step by Step):
- Take the WatchPAT at-home sleep test worn on the finger for two nights.
- Receive a physician review and full OSA diagnosis within 24 hours.
- Complete dental impressions at home using Daybreak’s guided impression kit.
- Receive your custom-built device and begin weekly remote titration support.
What Features Does the Daybreak Device Include?
The Daybreak device includes a fully at-home care pathway covering sleep testing, physician diagnosis, custom device fabrication, titration support, and a 3-year warranty on the finished device. The device is USA-made from lightweight materials designed for nightly long-term wear, portable enough to travel with anywhere.
FDA clearance covers both snoring and mild to moderate obstructive sleep apnea. Is that clearance meaningful? Yes — it means the device met US regulatory standards for safety and efficacy in this device classification. A patient care guarantee with refund eligibility under qualifying conditions is included with every order.
Daybreak’s clinical team includes board-certified dentists and physicians. Dental director Peter Balacky, DDS, leads the standardized virtual care model that the Cedars-Sinai study evaluated and validated.
Key Included Features:
- FDA-cleared for OSA and snoring
- Custom-fit from at-home dental impressions
- USA-made, lightweight, travel-portable design
- Remote titration with weekly adjustment guidance
- 3-year warranty and patient care guarantee
- FSA-eligible and covered by most insurance
Is the Daybreak Fitting Process Easy?
Yes. The Daybreak fitting process uses at-home dental impressions guided by a step-by-step instructional video, so patients never need a dentist’s office visit to get fitted. Daybreak ships the impression kit to the patient’s home after the physician issues a prescription, and the mold is taken at home and mailed back.
Many reviewers found the impression process quick and manageable. Others report delivery wait times of several weeks between completing impressions and receiving the finished device, which Daybreak attributes to the custom fabrication process.
Once received, the device adjusts in small increments over several weeks. Daybreak’s virtual support team guides the titration via remote check-ins, though some reviewers report inconsistent communication during this adjustment phase.
What Does the Daybreak At-Home Sleep Test Include?
The Daybreak at-home sleep test uses the WatchPAT device, an FDA-cleared finger-worn monitor that measures key sleep breathing indicators with 98% accuracy for detecting obstructive sleep apnea. The device pairs with a mobile app and transmits sleep data automatically to Daybreak’s physician team for overnight analysis.
Results return within 24 hours of completing the two-night test. A board-certified physician reviews the data and provides a full OSA diagnosis, which then determines eligibility for the Daybreak mandibular advancement device.
No sleep lab, no clinic visit, no technician. Reviewers who completed the sleep test consistently praised receiving ‘results within 24 hours’ compared to traditional in-lab sleep study timelines that can stretch for weeks.
What Are the Benefits of Daybreak?
Daybreak delivers a mask-free, clinic-free sleep apnea treatment that combines physician-directed diagnosis with a custom oral device built and titrated entirely at home. The benefits extend beyond convenience: portability, quiet use, custom fit, insurance coverage, and access to clinical-grade treatment without specialist wait times.
The device is quiet and compact. Users report improvements in energy, mood, and sleep quality within the first nights of consistent use. Some reviewers describe immediate symptom resolution. Is that typical? Based on the clinical data, yes — 83% of patients in the Cedars-Sinai study met full treatment success criteria.
In fact, insurance coverage and FSA eligibility make Daybreak accessible to a broader range of patients than most people expect. The good news? The full cost is often offset substantially for patients with standard employer-sponsored insurance or FSA plans.
Does Daybreak Actually Treat Sleep Apnea?
Yes. Daybreak demonstrated a mean apnea-hypopnea index (AHI) reduction of 63.3% in mild OSA patients and 60.95% in moderate OSA patients in a peer-reviewed study published in the American Journal of Clinical and Medical Research. The retrospective cohort study, conducted at Cedars-Sinai Medical Center by investigators including Martin L. Hopp, MD, PhD, evaluated 185 patients using Daybreak’s fully virtual care model.
Overall, 83% of the 185 patients met Sleep Health Experts Recommendations (SHER) criteria for treatment success. Among mild OSA patients specifically, 88% achieved a post-treatment AHI below 5 events per hour.
Beyond objective AHI reduction, 82% of all patients reported subjective improvement in snoring. That combination of objective data and patient-reported outcomes supports the real-world effectiveness of Daybreak’s approach.
Clinical Outcomes (Cedars-Sinai Cohort Study, n=185):
| Metric | Mild OSA | Moderate OSA |
|---|---|---|
| Pre-treatment AHI (events/hr) | 9.08 | 22.0 |
| Post-treatment AHI (events/hr) | 3.33 | 8.59 |
| AHI Reduction | 63.3% | 60.95% |
| Patients reaching AHI below 5 | 88% | 48% |
| Patients reaching AHI below 10 | 95% | 77% |
Can Daybreak Replace CPAP?
Yes. Daybreak can replace CPAP for mild to moderate OSA patients, particularly those who have discontinued continuous positive airway pressure therapy due to mask discomfort, noise, or difficulty maintaining nightly compliance. Both the AASM and AADSM recognize mandibular advancement devices as a clinically appropriate first-line alternative when CPAP is not tolerated.
CPAP achieves higher AHI reduction for severe OSA because it works at all severity levels. Daybreak is limited by both clinical guidelines and device design to the mild to moderate range, defined as an AHI below 30 events per hour.
The tradeoff is manageable for the right patient. Daybreak’s clinical evidence shows meaningful AHI reduction in its target population, with a much higher likelihood of consistent nightly use compared to CPAP machines that many patients abandon within the first year.
What Do Daybreak Reviews Say?
Daybreak reviews are mixed, with consistent praise for the device’s clinical effectiveness alongside recurring complaints about delivery delays, customer service responsiveness, and return policy confusion. Trustpilot shows a 3.0 out of 5 average score, reflecting a real split between strong clinical outcomes and documented service failures across a significant portion of customers.
The positive pattern is consistent: sleep quality improved, snoring reduced, energy increased. The negative pattern is also consistent: long wait times, unanswered emails, and confusion about return terms and timelines.
Worth knowing: the service issues appear concentrated at the delivery and early support phases. Patients who successfully move through the pathway to device use report much higher satisfaction than those who encounter problems before the device even arrives.
What Do Positive Daybreak Reviews Report?
Positive Daybreak reviewers report that the device ended sleep apnea symptoms quickly, returned sleep test results within 24 hours, and made a noticeable difference in sleep quality within the first nights of use. Multiple reviewers specifically cited a Daybreak staff member named Anna for providing knowledgeable and patient support throughout the onboarding process.
One reviewer’s AHI dropped from between 6 and 10 events per hour down to between 1 and 3 events per hour. Can results happen that fast? According to the Cedars-Sinai study, the median treatment completion time was 42 days. Another reviewer tracked snoring changes with the SnoreLab app and confirmed significant reductions in both volume and frequency.
Several reviewers praised skipping the dentist office and insurance coordination entirely. The portal-based experience was described as ‘modern and efficient’ by those who moved through the full Daybreak pathway without issue.
Common Positive Themes in Daybreak Reviews:
- Rapid or immediate symptom improvement after first use
- Sleep test results returned within 24 hours
- Confirmed AHI reduction in follow-up sleep testing
- Convenient fully at-home process with no clinic visits
- Friendly and knowledgeable patient support staff
What Are the Common Daybreak Complaints?
Common Daybreak complaints include delivery delays exceeding two months, aggressive follow-up calls, and slow or absent email responses when customers attempted to use the return policy within the stated window. One Trustpilot reviewer reported waiting more than two months with no device delivered and no reply to repeated communication attempts.
Return policy confusion is a recurring theme. One reviewer reported being told the return window was six months, but found the actual terms allowed only 30 days. Daybreak’s published policy states a 60-day money-back guarantee under qualifying conditions.
A subset of users experienced significant jaw or tooth pain with the device. These reviewers consistently note that titration adjustment requests went unanswered, leaving them without a path to resolving the discomfort through the clinical process.
Common Negative Themes in Daybreak Reviews:
- Delivery delays of 2 or more months without communication
- Aggressive or misleading sales calls during onboarding
- Unresponsive email support during the return window
- Return policy terms disputed or inconsistently explained
- Jaw or tooth pain with no available titration support
How Does Daybreak Compare to CPAP?
Compared to CPAP, Daybreak is mask-free, silent, and portable with no electricity or bedside machine required. Nightly use is fundamentally easier without machine noise or mask discomfort disrupting sleep. CPAP connects the patient to a bedside unit via a hose and mask and delivers continuous positive airway pressure to hold the airway open from the outside.
CPAP achieves higher AHI reduction across all severity levels, particularly for severe OSA. Daybreak is limited to mild and moderate OSA by both clinical guidelines and the nature of jaw repositioning therapy.
The bigger issue with CPAP is adherence. Does that matter for most patients? Absolutely. Research published across multiple journals confirms that CPAP abandonment rates are high, with a large portion of patients discontinuing use within the first year due to mask discomfort, dry mouth, and machine noise.
Daybreak vs CPAP Comparison:
| Feature | Daybreak | CPAP |
|---|---|---|
| Mask required | No | Yes |
| Electricity required | No | Yes |
| Travel-portable | Yes | Limited |
| OSA severity covered | Mild to Moderate | All severities |
| FDA-cleared | Yes | Yes |
| Guideline endorsement | AASM and AADSM (mild to moderate) | First-line for all |
Is Daybreak More Comfortable than CPAP?
Yes. Daybreak is consistently reported as more comfortable than CPAP by patients who have tried both, because there is no mask, no pressurized air, and no machine noise interrupting sleep. The custom-fit oral appliance fits entirely inside the mouth and is small enough to take on any trip without additional equipment.
Initial jaw soreness and tooth tenderness are common during the first few weeks of Daybreak use. These adjustment effects are standard for all mandibular advancement devices and typically resolve as the jaw adapts to the forward repositioning over time.
CPAP discomfort takes a different form: mask seal pressure, forced-air dry mouth, and motor noise are the most commonly cited issues. For patients who have already abandoned CPAP, Daybreak offers a categorically different wearing experience with its own but distinct adjustment curve.
Are There Side Effects from Daybreak?
Yes. Side effects from Daybreak include jaw soreness, initial tooth tenderness, and morning jaw muscle stiffness, all of which are common with any mandibular advancement device during the early adjustment period. Daybreak’s own patient care guarantee explicitly acknowledges that minor side effects are a normal part of the treatment experience.
The titration protocol, starting at 1 mm of jaw advancement with weekly 1 mm increases, is designed specifically to minimize these effects by avoiding rapid jaw protrusion. Gradual advancement gives the jaw musculature time to adapt before the next increment.
Significant or persistent pain is not typical. But here is the thing: reviewers who reported ongoing pain also reported difficulty reaching Daybreak’s support team. That combination is a meaningful concern, since timely titration adjustment guidance is the standard clinical response to persistent discomfort.
Who Should Avoid Daybreak?
Patients with severe obstructive sleep apnea should not use Daybreak as their primary treatment because mandibular advancement devices cannot achieve sufficient AHI reduction at severity levels above 30 events per hour. CPAP remains the only guideline-endorsed standard of care for severe OSA, and no oral device is an appropriate substitute.
Patients with active temporomandibular joint (TMJ) disorders, significant missing teeth, or dental conditions that prevent device retention are also not candidates for Daybreak. A physician assessment determines structural eligibility before any prescription is issued.
Children and patients with central sleep apnea rather than obstructive sleep apnea fall outside Daybreak’s indicated use. In plain English: Daybreak moves the jaw to open the airway. That works for obstruction, not for the neurological disruptions that define central apnea events.
Who Should Not Use Daybreak:
- Patients with severe OSA (AHI above 30 events per hour)
- Patients with active temporomandibular joint (TMJ) disorders
- Patients with insufficient teeth to support the device
- Children (device is designed for adult patients only)
- Patients with central sleep apnea rather than obstructive sleep apnea
Is Daybreak Legit?
Yes. Daybreak is a legitimate medical device company backed by peer-reviewed clinical research, FDA clearance, physician oversight, and endorsement from the AASM and AADSM. The company is not a scam. Whether the device is the right fit for a specific patient is a separate question entirely from whether the company itself is real and lawfully operating.
The Cedars-Sinai cohort study, published in the American Journal of Clinical and Medical Research and led by investigators including Martin L. Hopp, MD, PhD, provides independent clinical validation of Daybreak’s treatment model. That is not the work of a fraudulent operation.
Customer service complaints on Trustpilot are real and documented, but they reflect operational issues at the service layer — not product fraud. Short answer: a 3.0 Trustpilot score reflects a company with proven clinical outcomes that has also generated documented service failures for a portion of its customers.
Is Daybreak FDA Cleared?
Yes. Daybreak is FDA-cleared for the treatment of both obstructive sleep apnea and snoring, meeting US Food and Drug Administration standards for devices in this medical device classification. FDA clearance means the device was reviewed and determined to be substantially equivalent to a legally marketed predicate device within the same category.
FDA clearance is not the same as FDA approval. Does that distinction matter? Yes. Clearance applies to devices sharing an established regulatory predicate. The mandibular advancement device class has a regulatory history spanning more than 30 years in the US market, making the predicate well-established.
The WatchPAT at-home sleep test used in Daybreak’s diagnostic pathway also carries its own independent FDA clearance. Both components of the Daybreak system are separately regulated and cleared in the United States.
How Much Does Daybreak Cost?
Daybreak’s total cost depends on insurance coverage, but reviewers consistently describe the out-of-pocket price as expensive relative to over-the-counter anti-snoring devices and comparable to other custom oral appliances ordered through a dentist’s office. The company does not publish a single flat price, as costs vary based on insurance plan, sleep test fees, and device pricing for each patient.
Daybreak is FSA-eligible. Patients can apply pre-tax flexible spending account dollars to both the at-home sleep test and the device itself, reducing the effective out-of-pocket cost for those with employer-sponsored FSA access.
Daybreak’s support team handles insurance processing for patients. Most standard insurance plans are accepted, though coverage terms vary and patients should confirm eligibility before placing a device order.
Is Daybreak Worth the Price?
Yes. For patients who achieve successful treatment, Daybreak is worth the price because clinical evidence shows an 83% treatment success rate and the device eliminates the recurring costs of CPAP supplies, filters, and ongoing in-clinic sleep specialist appointments. The Cedars-Sinai study confirmed that 95% of mild OSA patients achieved a post-treatment AHI below 10 events per hour.
For patients who experience delivery delays or unresponsive customer service, the value drops sharply. Does the price still hold up? Not for that group. Negative reviewers frequently cite the expense as an amplifier of frustration when service issues emerge alongside a significant wait and cost.
The 60-day money-back guarantee provides a partial risk buffer. Patients should confirm the exact return terms and their insurance coverage before ordering, given the return policy disputes that appear across multiple Trustpilot reviews.
Does Insurance Cover Daybreak?
Yes. Daybreak is covered by most insurance plans for the treatment of diagnosed obstructive sleep apnea, and Daybreak processes insurance claims on behalf of patients as part of the standard onboarding process. FSA eligibility applies to both the at-home sleep test and the Daybreak device itself.
Coverage depends on the specific insurance plan and the OSA severity confirmed by diagnosis. Patients with mild or moderate OSA and a physician prescription are generally eligible for device coverage under sleep-related durable medical equipment (DME) benefits.
Patients should contact Daybreak directly to verify coverage before ordering. For example, the company states that most insurance is accepted and that all paperwork is handled by Daybreak staff without requiring patients to contact their insurer independently.
Is Daybreak Worth It?
Yes. Daybreak is worth it for patients with mild to moderate obstructive sleep apnea who cannot tolerate CPAP and want a clinically validated, fully at-home treatment supported by physician oversight and peer-reviewed evidence. The Cedars-Sinai cohort study, FDA clearance, and endorsements from the AASM and AADSM collectively support Daybreak as a legitimate and effective treatment within its indicated patient group.
The service inconsistencies are a real concern. Will Daybreak improve? That is unknown. Think of it this way: the device delivers, but the support system around it does not always keep pace. Patients who need fast, responsive titration support should account for this risk based on documented negative experiences.
Bottom line: the device works, the science is solid, and the at-home concept is well-executed at the clinical level. Where Daybreak falls short is in the customer service execution, and that gap matters most for patients who encounter problems after ordering.
Should You Try Daybreak?
Yes. Daybreak is a strong option for patients with mild to moderate OSA who have already tried or ruled out CPAP and want a fully at-home treatment pathway backed by clinical evidence, physician oversight, and a 3-year device warranty. It is not appropriate for severe OSA patients or for anyone who requires fast, responsive support throughout the treatment and titration process.
Before ordering, verify insurance coverage, confirm the current delivery timeline directly with Daybreak, and understand the exact return window and qualifying conditions. Is that extra step worth it? Yes. This preparation significantly reduces the risk of the service-related frustrations that dissatisfied reviewers describe.
The Cedars-Sinai study findings, the AASM and AADSM clinical guidelines endorsing MAD therapy, and the consistent positive outcomes reported by satisfied patients all support Daybreak as a clinically effective and legitimate option for the right patient population.